EP2998289
Efnasambönd til að gera lyfjagjöf marksækna og auka sirna virkni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.6.2012EP published:
7.8.2019EP application number:
15181729.3
EP translation filed:
16.8.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
7.6.2032Expiry date:
7.6.2026Next due date:
30.6.2026
Title:
COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING SIRNA ACTIVITY
Timeline
Today
8.6.2012EP application
7.8.2019EP Publication
16.8.2019Translation submitted
15.9.2019Registration published
7.6.2026Expires
Owner
Name:
NITTO DENKO CORPORATIONAddress:
1-1-2, Shimohozumi, 567-8680, Ibaraki-shi, Osaka, JP
Inventor
Name:
Sridhar, C. NagarajanAddress:
San Diego, CA, US
Name:
Karmali, PriyaAddress:
San Diego, CA, US
Name:
Payne, Joseph E.Address:
Oceanside, CA, US
Name:
Hou, ZhengAddress:
San Diego, CA, US
Name:
Gaudette, John A.Address:
Poway, CA, US
Name:
Knopov, VictorAddress:
Oceanside, CA, US
Name:
Witte, Richard P.Address:
San Diego, CA, US
Name:
Ahmadian, MohammadAddress:
Carlsbad, CA, US
Name:
Perelman, Loren A.Address:
San Diego, CA, US
Name:
Tanaka, YasunobuAddress:
Osaka, , JP
Name:
Akopian, ViolettaAddress:
Oceanside, CA, US
Name:
Niitsu, YoshiroAddress:
Sapporo-shiHokkaido, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161494710 PDate:
8.6.2011Country:
US
Number:
201161494840 PDate:
8.6.2011Country:
US
Classification
Categories:
C07C 237/08, A61K 31/16, A61P 1/16, C07C 237/22, C07C 323/60, C07C 333/04, A61K 9/127
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 5.5.2020
Expires: 7.6.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.5.2021
Expires: 7.6.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 6.5.2022
Expires: 7.6.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 24.5.2023
Expires: 7.6.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.5.2024
Expires: 7.6.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.5.2025
Expires: 7.6.2026
Payer: Árnason Faktor ehf.